Edris Badreddin's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Jun 5, 2024
- Accession no.
- 0001104659-24-068673
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $801.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edris BadreddinCIK 0001786966 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | SSaleDisposed | −11,772 | $39.40 | −$463,816.8 | 257,828 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −4,192 | $40.62 | −$170,279.04 | 253,636 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −3,651 | $41.38 | −$151,078.38 | 249,985 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −385 | $42.04 | −$16,185.4 | 249,600 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.